Visualitzant per matèria 

Visualitzant per matèria "Difuse large B cell lymphoma (DLBCL)"

Ara mostrant els elements 1-1 de 1

    • Mutated RAS-associating proteins and ERK activation in relapse/refractory diffuse large B cell lymphoma 

      Benoit, Alexandre; Bou Petit, Elisabeth; Chou, Hsiang; Lu, Melissa; Guilbert, Cynthia; Mingyi Luo, Vincent; Assouline, Sarit; Morin, Ryan D; Dmitrienko, Svetlana; Estrada Tejedor, Roger; Johnson, Nathalie A.; Mann, Koren K. (Scientific Reports 2022, 12, 779, 2022)
      Diffuse large B cell lymphoma (DLBCL) is successfully treated with combination immuno-chemotherapy, but relapse with resistant disease occurs in ~ 40% of patients. However, little is known regarding ...